§ 19a-111 — (Formerly Sec. 19-65f). Informational materials. On-site inspection. Investigation. Preventive measures. Relocation of families. Reports. Regulations.

Connecticut § 19a-111

• Jurisdiction: Connecticut
• Title 19a: Public Health and Well-Being
• Ch. 368a: Department of Public Health

Text

(a) The Commissioner of Public Health shall develop informational materials describing the dangers of lead poisoning, precautions to reduce the risk of lead poisoning, potential eligibility for services for children from birth to three years of age pursuant to sections 17a-248 to 17a-248i, inclusive, laws and regulations concerning lead abatement and any other information as prescribed by the commissioner. The director of health of the town, city, borough or district shall provide, or cause to be provided, such informational materials to the parent or guardian of a child who is (1) known to have a blood lead level of three and one-half micrograms per deciliter of blood or more, or (2) the subject of a report by an institution or clinical laboratory, pursuant to section 19a-110. The director of health need only provide, or cause to be provided, such information to such parent or guardian on one occasion after receipt of an initial report of an abnormal blood lead level as described in section 19a-110. (b) Upon receipt of each report of a child with a blood lead level (1) equal to or greater than ten micrograms per deciliter but less than fifteen micrograms per deciliter on or before January 1, 2024, and (2) equal to or greater than five micrograms per deciliter but less than ten micrograms per deciliter from January 1, 2024, to December 31, 2024, inclusive, the director shall conduct an on-site inspection to identify the source of the lead causing such blood lead level and order remediation of such source by the appropriate persons responsible for the conditions at such source. (c) Upon receipt of each report of a blood lead level equal to or greater than fifteen micrograms per deciliter of blood from January 1, 2023, to December 31, 2023, inclusive, ten micrograms per deciliter of blood from January 1, 2024, to December 31, 2024, inclusive, and five micrograms per deciliter of blood on and after January 1, 2025, the local director of health shall make or cause to be made an epidemiological investigation of the source of the lead causing the increased lead level or abnormal body burden and shall order action to be taken by the appropriate person responsible for the condition that brought about such lead poisoning as may be necessary to prevent further exposure of persons to such poisoning. In the case of any residential unit where such action will not result in removal of the hazard within a reasonable time, the local director of health shall utilize such community resources as are available to effect relocation of any family occupying such unit. The local director of health may permit occupancy in said residential unit during abatement if, in such director's judgment, occupancy would not threaten the health and well-being of the occupants. (d) The local director of health shall, not later than thirty days after the conclusion of such director's epidemiological investigation, report to the commissioner, using a web-based surveillance system as prescribed by the commissioner, the result of such investigation and the action taken to ensure against further lead poisoning from the same source, including any measures taken to effect relocation of families. Such report shall include information relevant to the identification and location of the source of lead poisoning and such other information as the commissioner may require pursuant to regulations adopted in accordance with the provisions of chapter 54. Nothing in this section shall be construed to prohibit a local building official from requiring abatement of sources of lead or to prohibit a local director of health from making or causing to be made an epidemiological investigation upon receipt of a report of a blood lead level that is less than the minimum blood level specified in this section. See Sec. 20-474 for applicable definitions.

Legislative History

(1971, P.A. 22, S. 2; P.A. 77-614, S. 323, 610; P.A. 87-394, S. 2, 7; P.A. 92-192, S. 2, 5; P.A. 93-321, S. 2, 6; 93-381, S. 9, 39; P.A. 95-257, S. 12, 21, 58; P.A. 14-231, S. 8; P.A. 21-121, S. 5; P.A. 22-49, S. 2; 22-118, S. 150; P.A. 23-31, S. 31.) History: P.A. 77-614 replaced commissioner of health with commissioner of health services, effective January 1, 1979; Sec. 19-65f transferred to Sec. 19a-111 in 1983; P.A. 87-394 added provisions re contents of reports, regulations, quarterly summaries and guidelines; P.A. 92-192 added provision that a blood lead level greater than twenty micrograms per deciliter of blood will cause an investigation to be conducted and added provisions that the guidelines established by the commissioner be consistent with those of the National Centers for Disease Control for assessment of the risk of lead poisoning, screening for lead poisoning and follow-up care; P.A. 93-321 added provision permitting occupancy during abatement, changed “may” to “shall” re establishment of guidelines, added treatment including children, pregnant women and women planning pregnancy and added provision affirming building officials' right to require abatement; P.A. 93-381 replaced commissioner of health services with commissioner of public health and addiction services, effective July 1, 1993; P.A. 95-257 replaced Commissioner and Department of Public Health and Addiction Services with Commissioner and Department of Public Health, effective July 1, 1995; P.A. 14-231 deleted provision re quarterly summary of records and made technical changes; P.A. 21-121 added provision re use of web-based surveillance system as prescribed by the commissioner and made technical change; P.A. 22-49 decreased blood lead level minimum from 20 micrograms per deciliter to 15 micrograms per deciliter for January 1, 2023, to December 31, 2024, added provisions re minimum blood lead level from January 1, 2024, to December 31, 2024, and on and after January 1, 2025, and added provision permitting a director of health to investigate a report of a confirmed blood lead level less than the minimum specified in this section, effective January 1, 2023; P.A. 22-118 made identical changes as P.A. 22-49, effective January 1, 2023; P.A. 23-31 added Subsec. (a) re informational materials and Subsec. (b) re on-site inspections, designated existing provisions as Subsecs. (c) and (d), amended Subsecs. (c) and (d) by deleting “confirmed venous”, “venous”, and provisions re maintenance of comprehensive records and establishment of lead assessment and screening guidelines, and made technical and conforming changes. Cited. 45 CS 136.